Company Analysis

Kyverna Therapeutics, Inc. (KYTX)

Nasdaq: KYTX · Biological Products, (No Diagnostic Substances) · Emeryville, CA · filing with the SEC since 2023
Grade4.6
◀ Past 4.0● Present 4.2▶ Future 5.4
6 est.

Filings

116 filings since 2017 beside 73 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 13, 2026.

Filings a yearinsider forms included
10705158
2023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest May 18, 2026.SEC letters: 12 in the last 36 months, the newest Mar 31, 2026.
Insider forms 73

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 19, 2026 SCHEDULE 13G Large holder notice
Sep 24, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 11, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 29, 2026 SCHEDULE 13G Large holder notice
Jul 27, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Jul 23, 2026
Jul 9, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jul 8, 2026
Jun 2, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report May 27, 2026
May 18, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report May 14, 2026
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 2.02, 9.01 Results released · Current report
May 4, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Apr 21, 2026
Apr 20, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 13, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 13, 2026 DEFA14A Extra proxy material
Apr 13, 2026 DEF 14A Proxy statement May 27, 2026
Apr 2, 2026 EFFECT Registration effective
Apr 2, 2026 424B5 Shelf offering
Mar 31, 2026 CORRESP Reply to the SEC
Mar 30, 2026 UPLOAD SEC comment letter
Mar 26, 2026 S-8 Employee stock plan registration
Mar 26, 2026 S-3 Shelf registration
Mar 26, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 24, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 6, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 3, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Jan 29, 2026
Jan 12, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Jan 8, 2026
Dec 18, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Dec 17, 2025
Dec 18, 2025 424B5 Shelf offering
Dec 17, 2025 FWP Offering communication
Dec 15, 2025 424B5 Shelf offering
Dec 15, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
40 of 116 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton KYTX · research, not advice